ZA200105407B - Taste-Masked Pharmaceutical Particles. - Google Patents

Taste-Masked Pharmaceutical Particles.

Info

Publication number
ZA200105407B
ZA200105407B ZA200105407A ZA200105407A ZA200105407B ZA 200105407 B ZA200105407 B ZA 200105407B ZA 200105407 A ZA200105407 A ZA 200105407A ZA 200105407 A ZA200105407 A ZA 200105407A ZA 200105407 B ZA200105407 B ZA 200105407B
Authority
ZA
South Africa
Prior art keywords
taste
pharmaceutical particles
masked pharmaceutical
masked
particles
Prior art date
Application number
ZA200105407A
Other languages
English (en)
Inventor
Daniel Mcteigue
David W Wynn
Narendra Parikh
Ravivaj S Pillai
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of ZA200105407B publication Critical patent/ZA200105407B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200105407A 2000-06-30 2001-06-29 Taste-Masked Pharmaceutical Particles. ZA200105407B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21550500P 2000-06-30 2000-06-30

Publications (1)

Publication Number Publication Date
ZA200105407B true ZA200105407B (en) 2003-01-02

Family

ID=22803235

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200105407A ZA200105407B (en) 2000-06-30 2001-06-29 Taste-Masked Pharmaceutical Particles.

Country Status (17)

Country Link
US (2) US7223421B2 (xx)
EP (1) EP1166777B1 (xx)
JP (1) JP2002087952A (xx)
KR (1) KR20020002321A (xx)
CN (1) CN1356102A (xx)
AR (1) AR029546A1 (xx)
AT (1) ATE404180T1 (xx)
AU (1) AU784613B2 (xx)
BR (1) BR0103033A (xx)
CA (1) CA2351814C (xx)
CO (1) CO5271674A1 (xx)
DE (1) DE60135273D1 (xx)
ES (1) ES2311500T3 (xx)
MX (1) MXPA01006803A (xx)
NZ (1) NZ512683A (xx)
SA (1) SA01220402B1 (xx)
ZA (1) ZA200105407B (xx)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
UA55507C2 (uk) 1997-12-22 2003-04-15 Еро-Селтік, С.А. Лікарська форма для перорального введення та спосіб запобігання зловживанню пероральною опіоїдною композицією
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient
US8268333B2 (en) 2001-04-24 2012-09-18 Lintec Corporation Orally administered agent and an orally administered agent/supporting substrate complex
DE60238756D1 (de) 2001-05-11 2011-02-10 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
IL164106A0 (en) * 2002-04-04 2005-12-18 Pfizer Prod Inc Palatable chewable tablet
HUE032656T2 (en) * 2002-04-05 2017-10-30 Euro Celtique Sa Pharmaceutical composition containing oxicodone and naloxone
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20040258752A1 (en) * 2003-01-31 2004-12-23 Paruthi Manoj Kumar Taste masking pharmaceutical composition and process for its preparation
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
US20040213838A1 (en) * 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
US20040265372A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US20040265373A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
WO2005000358A1 (ja) * 2003-06-27 2005-01-06 Wakunaga Pharmaceutical Co., Ltd. 安定液剤
JP3881640B2 (ja) * 2003-08-08 2007-02-14 塩野義製薬株式会社 ロラタジンを含むドライシロップ剤
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8062659B2 (en) * 2004-02-20 2011-11-22 Novartis Ag Dietary fiber composition
US20050186271A1 (en) * 2004-02-24 2005-08-25 Sheskey Paul J. Process for dispersing a fluid in a mass of solid particles
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
ITMI20042356A1 (it) * 2004-12-10 2005-03-10 Acraf Composizione farmaceutica orodisperdibile e procedimento per prepararla
CN101132772B (zh) * 2005-01-28 2012-05-09 欧洲凯尔特公司 耐醇剂型
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1813276A1 (en) * 2006-01-27 2007-08-01 Euro-Celtique S.A. Tamper resistant dosage forms
WO2007123153A1 (ja) * 2006-04-19 2007-11-01 Ono Pharmaceutical Co., Ltd. 経口投与用カプセル
US20070264335A1 (en) * 2006-05-09 2007-11-15 Sherman Bernard C Modified release tablets comprising tramadol
CA2654402A1 (en) * 2006-06-01 2007-12-06 Adel Penhasi Multiple unit pharmaceutical formulation
WO2008008801A2 (en) * 2006-07-11 2008-01-17 Mcneil Nutritionals, Llc Solid oral dosage vitamin and mineral compositions
AU2007308986A1 (en) * 2006-10-25 2008-05-02 Mcneil-Ppc, Inc. Ibuprofen composition
FR2930147B1 (fr) * 2008-04-18 2013-02-08 Flamel Tech Sa Forme orale solide dotee d'un double profil de liberation
US20110177133A1 (en) * 2008-07-07 2011-07-21 Michael Hopp Use of opioid antagonists for treating urinary retention
SG174286A1 (en) 2009-03-10 2011-10-28 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US20100239681A1 (en) * 2009-03-20 2010-09-23 Biokey, Inc. Controlled Release Particulates Containing Water-Insoluble Drug
ES2543108T3 (es) * 2010-03-31 2015-08-14 Mochida Pharmaceutical Co., Ltd. Preparación sólida fácilmente administrable
CN107049979B (zh) 2011-09-30 2020-08-14 持田制药株式会社 易服用性固体制剂
FR2999426B1 (fr) * 2012-12-13 2015-01-02 Flamel Tech Sa Forme orale multiparticulaire a liberation immediate d'au moins un compose actif, comprenant des particules enrobees resistantes au broyage.
JP5836980B2 (ja) 2013-01-11 2015-12-24 信越化学工業株式会社 薬物含有粒子、固形製剤及び薬物含有粒子の製造方法
AU2014295042B2 (en) 2013-07-23 2017-03-30 Mundipharma Pty Limited A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN112674348A (zh) * 2020-12-23 2021-04-20 石药集团中诺药业（泰州）有限公司 一种b族维生素含片和咀嚼片制备方法
WO2024020361A2 (en) * 2022-07-19 2024-01-25 Michael Ogburn Inhalable serotonin receptor agonist formulations

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS48103718A (xx) 1972-04-14 1973-12-26
US4160827A (en) * 1978-02-06 1979-07-10 The Upjohn Company Metronidazole phosphate and salts
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
JPS57120518A (en) * 1981-01-19 1982-07-27 Tanabe Seiyaku Co Ltd Preparation of microcapsule
US4749575A (en) * 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
CA2063141C (en) * 1989-08-04 1997-03-04 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
IT1246383B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
FI922107A0 (fi) 1991-05-10 1992-05-08 Faulding F H & Co Ltd Mikrokapselkomposition och foerfarande.
US5837277A (en) * 1992-06-04 1998-11-17 Smithkline Beecham Corporation Palatable pharmaceutical compositions
ATE195252T1 (de) * 1993-04-23 2000-08-15 Novartis Erfind Verwalt Gmbh Wirkstoffabgabevorrichtung mit gesteuerter freigabe
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
GB9317897D0 (en) * 1993-08-27 1993-10-13 Plessey Telecomm Telecommunications switching element
JPH07223970A (ja) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
US5536507A (en) * 1994-06-24 1996-07-16 Bristol-Myers Squibb Company Colonic drug delivery system
JP3355593B2 (ja) * 1994-08-19 2002-12-09 信越化学工業株式会社 固形腸溶製剤の製造方法
WO1998014179A1 (en) * 1996-10-01 1998-04-09 Cima Labs Inc. Taste-masked microcapsule compositions and methods of manufacture
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations

Also Published As

Publication number Publication date
CN1356102A (zh) 2002-07-03
BR0103033A (pt) 2002-03-05
US20070196489A1 (en) 2007-08-23
CA2351814A1 (en) 2001-12-30
ES2311500T3 (es) 2009-02-16
AU5415801A (en) 2002-01-03
US7223421B2 (en) 2007-05-29
CO5271674A1 (es) 2003-04-30
ATE404180T1 (de) 2008-08-15
US20020031552A1 (en) 2002-03-14
AU784613B2 (en) 2006-05-11
EP1166777A1 (en) 2002-01-02
EP1166777B1 (en) 2008-08-13
CA2351814C (en) 2009-11-17
JP2002087952A (ja) 2002-03-27
DE60135273D1 (de) 2008-09-25
NZ512683A (en) 2003-02-28
MXPA01006803A (es) 2003-08-20
AR029546A1 (es) 2003-07-02
SA01220402B1 (ar) 2007-02-07
KR20020002321A (ko) 2002-01-09

Similar Documents

Publication Publication Date Title
ZA200105407B (en) Taste-Masked Pharmaceutical Particles.
ZA200003997B (en) Pharmaceutical compositions.
ZA200208163B (en) Pharmaceutical compositions comprising fluvastatin.
ZA200101012B (en) Pharmaceutical combinations.
GB0006133D0 (en) Novel pharmaceutical
MXPA01012478A (es) Formulaciones farmaceuticas mejoradas.
GB0025473D0 (en) Pharmaceutical combinations
GB0020691D0 (en) Pharmaceutical combination
ZA200203707B (en) Pharmaceutical combinations.
MXPA03002105A (es) Composiciones farmaceuticas.
GB0012291D0 (en) Pharmaceutical combination
ZA200110454B (en) Pharmaceutical complex.
ITMI20001848A0 (it) Faramaci per l'incontinenza.
GB0021865D0 (en) Novel pharmaceutical
GB0019228D0 (en) Novel pharmaceutical
GB0014006D0 (en) Novel pharmaceutical
GB0019226D0 (en) Novel pharmaceutical
GB0019224D0 (en) Novel pharmaceutical
GB0021487D0 (en) Pharmaceutical
GB0014005D0 (en) Novel pharmaceutical
GB0023971D0 (en) Novel pharmaceutical
GB0012293D0 (en) Pharmaceutical combination
GB0023970D0 (en) Novel pharmaceutical
GB0021785D0 (en) Novel Pharmaceutical
HRP20030067A2 (en) Novel pharmaceutical